Wegovy is a prescription medication that contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist
These medications mimic the incretin hormones that the body usually produces to stimulate insulin secretion in response to meals, thereby helping regulate blood sugar levels
Neurological and Cognitive Benefits Comprehensive population-based studies reveal protective effects against neurodegenerative diseases ^8^38
Keep reading Published on: February 18, 2026 KevinCare There arent many people out there who can say they survived cardiac arrest at 30
Close 3 Mar 2026 | ~03:18 Engagement Time Many people living with multiple sclerosis are already taking GLP-1 medications or seriously considering them for weight management, diabetes, or metabolic health
In recent years, several main relevant mechanisms of the novel antidiabetic drugs in preclinical model of diabetic HFpEF were investigated (Table 5)